Prevention of vertical HIV transmission:: additive protective effect of elective Cesarean section and zidovudine prophylaxis

被引:150
作者
Kind, C
Rudin, C
Siegrist, CA
Wyler, CA
Biedermann, K
Lauper, U
Irion, O
Schüpbach, J
Nadal, D
机构
[1] Kantonsspital, Frauenklin, Div Neonatol, CH-9007 St Gallen, Switzerland
[2] Univ Basel, Childrens Hosp, Basel, Switzerland
[3] Univ Geneva, Childrens Hosp, Geneva, Switzerland
[4] Womens Hosp, Chur, Switzerland
[5] Univ Zurich, Womens Hosp, Zurich, Switzerland
[6] Univ Geneva, Womens Hosp, Geneva, Switzerland
[7] Univ Zurich, Natl Ctr Retroviruses, Zurich, Switzerland
[8] Univ Zurich, Childrens Hosp, Infect Dis Unit, Zurich, Switzerland
关键词
epidemiology; vertical transmission; Cesarean section; zidovudine;
D O I
10.1097/00002030-199802000-00011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To study the effect of elective Cesarean section and zidovudine prophylaxis on vertical HIV transmission. Design: Prospective study. Setting: Obstetric and paediatric clinics in Switzerland. Participants: Children of mothers with HIV infection identified before or at delivery. Interventions: Routine use of elective Cesarean section for HIV-infected parturients by some Swiss centres since 1985. National recommendation for zidovudine prophylaxis in mid-1994. Main outcome measure: HIV infection status of children. Results: In a cohort of 494 children born at least 6 months before the analysis date, 67 out of 414 children with known infection status were found to be infected, giving an overall transmission rate of 16.2% [95% confidence interval (CI), 13.0-18.5]. Elective Cesarean section with intact membranes and without previous labour was associated with a lower transmission rate of 6% [odds ratio (OR), 0.29; 95% CI, 0.12-0.70; P = 0.006 versus other delivery modes]. Transmission rate was intermediate after spontaneous delivery or non-elective Cesarean section (18%), and higher after obstetric interventions (27%; test for trend, P < 0.001). Since mid-1994, 78% of all women with registered pregnancies have received some form of zidovudine prophylaxis. Transmission rate was reduced from 17 to 7% after any zidovudine exposure (OR, 0.4; 95% CI, 0.11-1.41). Combined use of elective Cesarean section and zidovudine resulted in a 0% transmission rate (none out of 31), compared with 8% (seven out of 86) after elective Cesarean section without zidovudine, 17% (four out of 24) after zidovudine alone, and 20% (55 out of 271) after no intervention. Conclusions: Elective Cesarean section and zidovudine prophylaxis appear to have an additive effect in the prevention of vertical HIV transmission.
引用
收藏
页码:205 / 210
页数:6
相关论文
共 16 条
[1]  
[Anonymous], MMWR
[2]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[3]   Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission - Effect of maternal zidovudine treatment on viral load [J].
Dickover, RE ;
Garratty, EM ;
Herman, SA ;
Sim, MS ;
Plaeger, S ;
Boyer, PJ ;
Keller, M ;
Deveikis, A ;
Stiehm, ER ;
Bryson, YJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (08) :599-605
[4]  
DUNN DT, 1994, J ACQ IMMUN DEF SYND, V7, P1064
[5]   EFFECTS OF ZIDOVUDINE USE DURING PREGNANCY ON RESISTANCE AND VERTICAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
FRENKEL, LM ;
WAGNER, LE ;
DEMETER, LM ;
DEWHURST, S ;
COOMBS, RW ;
MURANTE, BL ;
REICHMAN, RC .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1321-1326
[6]  
KIND C, 1995, EUR J PEDIATR, V154, P542, DOI 10.1007/BF02074831
[7]   EPIDEMIOLOGY OF VERTICALLY TRANSMITTED HIV-1 INFECTION IN SWITZERLAND - RESULTS OF A NATIONWIDE PROSPECTIVE-STUDY [J].
KIND, C ;
BRANDLE, B ;
WYLER, CA ;
CALAME, A ;
RUDIN, C ;
SCHAAD, UB ;
SCHUPBACH, J ;
SENN, HP ;
PERRIN, L ;
MATTER, L .
EUROPEAN JOURNAL OF PEDIATRICS, 1992, 151 (06) :442-448
[8]   Cesarean deliveries and maternal-infant HIV transmission: Results from a prospective study in South Africa [J].
Kuhn, L ;
Bobat, R ;
Coutsoudis, A ;
Moodley, D ;
Coovadia, HM ;
Tsai, WY ;
Stein, ZA .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 11 (05) :478-483
[9]  
Mandelbrot L, 1996, AM J OBSTET GYNECOL, V175, P661
[10]  
NEWELL ML, 1994, LANCET, V343, P1464